Search result for 'winlevi'

Glenmark & Cosmo receive EU marketing authorization for Winlevi (clascoterone cream) to treat acne vulgaris in 15 European countries.

Sun Pharma is working to resolve USFDA compliance issues at three facilities: Halol, Mohali, and Dadra. The company is implementing CAPA and anticipates mid to high single-digit growth in FY26.

Glenmark Pharmaceuticals and Cosmo Pharmaceuticals have received MHRA approval for Winlevi, a topical treatment for acne vulgaris in the UK. This partnership expands Glenmark's dermatology portfolio.

Glenmark Pharmaceuticals reported a two-fold increase in net profit to Rs 340 crore for Q1 FY24, driven by strong revenue growth and improved margins.